Potential Health Policy Administrative Actions Under President Biden

This brief outlines the potential health policy actions that President Biden could take using executive authority, based on campaign pledges, and actions that would reverse or modify regulations or guidance issued by the Trump Administration.

Brief Examines What’s Known About Children and Coronavirus Transmission as Schools Prepare for Fall

With schools nationwide preparing for fall and the federal government encouraging in-person classes, key concerns for school officials, teachers and parents include the risks that coronavirus poses to children and their role in transmission of the disease. A new KFF brief examines the latest available data and evidence about the issues around COVID-19 and children andMore

Online Event: Highlights from the Virtual AIDS 2020 Conference

Earlier this month, the International AIDS Conference – the world’s largest conference on HIV and AIDS – took place on a virtual stage. Over five days, the conference showcased the latest research and analysis by leaders in the HIV sector. On Friday, July 24, 9:00 a.m. -10:00 a.m., the CSIS Global Health Policy Center and KFF (the Kaiser Family Foundation) will hostMore

COVID-19 Coronavirus Tracker – Updated as of July 10

This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 7.2 million confirmed cases and 411,000 confirmed deaths worldwide. There have been nearly 2 million confirmed cases and 112,000 confirmed deaths in the United States.

Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019

Women and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time as well as by country, to better understand the extent of its reach.

KFF/UNAIDS Analysis Finds Donor Governments Spent US$7.8 Billion for HIV in 2019, Down Almost $200 Million From the Previous Year

Half of the 14 donor governments analyzed in the study decreased their spending on global HIV efforts from 2018 to 2019; six increased; and one held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2019

This report from KFF and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds donor government disbursements to combat HIV in low- and middle-income countries totaled US$7.8 billion in 2019, a reduction from the US$8 Billion in 2018 and nearly the same as the funding levels of a decade ago.

UNFPA Funding & Kemp-Kasten: An Explainer

This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population Fund (UNFPA).